a syndrome which may involve ovarian enlargement, gastrointestinal symptoms, abdominal distension and weight gain. Severe cases may be further complicated with cardiovascular, pulmonary and electrolyte disturbances, requiring hospitalization.
results from an overstimulation of the ovary by hormonal treatment. In its moderate form, it is characterised in particular by enlarged ovaries due to big ovarian cysts. In its more severe form it can be potentially life threatening.
(OHSS) A complication of ovulation induction with, usually, follicle stimulating hormone, especially in cycles of superovulation for assisted conception, when it is intended to retrieve more than one egg. The ovaries become large, they can be painful, and there is excessive fluid released into the abdomen (the peritoneal cavity). Either removing this fluid or the occurrence of vomiting can cause dehydration, thickening of the blood and, occasionally, a serious thrombosis, such as a stroke. Death has been reported. Moderate to severe OHSS is treated in hospital, with administration of fluid intravenously, sometimes including albumin. See also: vascular endothelial growth factor
a serious medical condition resulting from an over-stimulating of the ovaries; it can cause a rapid accumulation of fluid in the abdomen and lungs; early warning signs include sever pelvic pain, nausea, vomiting and weight gain.
OHSS is a serious medical condition that occurs when the ovaries have been overstimulated. Ovaries become enlarged and fluid accumulates in the abdomen. Symptoms to report to your doctor include nausea, vomiting, weight gain, pelvic pain, and difficulty breathing. OHSS is rare and can be avoided in most cases with careful monitoring.
Sudden ovarian enlargement accompanied by fluid accumulation in the abdominal cavity. This may occur with or without pain, and with or without accumulation of fluid in the lungs. OHSS is caused when the ovaries become over stimulated by the various hormones that cause follicular development.
This is a painful condition caused when the ovaries become over stimulated by the various hormones that cause follicular development
A condition that may result from ovulation induction characterized by enlargement of the ovaries, fluid retention, and weight gain.
A rare but serious consequence of taking the drugs used to stimulate the ovaries.
A potentially life-threateningcondition following ovulation induction treatment. OHSS arises when too manyfollicles develop and hCG is given to release the eggs. This condition maybe prevented by withholding hCG when ultrasound monitoring indicates thatthere are a large number of follicles in the ovaries. IF OHSS is evident duringan IVF cycle, all the embryos may be frozen at the pronuclear stage (the dayafter the egg collection) and replaced at a later date when the conditionhas subsided as pregnancy can exacerbate the symptoms of OHSS.
A serious complication following stimulation of the ovaries with gonadotrophin drugs.
A potentially dangerous condition that can result after ovarian stimulation and ovulation or follicle aspiration in which vasoactive elements from the corpus luteum release fluid from blood vessels into the abdominal cavity. This can result in dehydration, clot formation, or difficulty in breathing.
A rare but potentially deadly complication during ovulatory therapy where ovaries develop too many follicles.
A possible side effect of medically induced ovulation, characterized by swollen, painful ovaries and, in some cases, the accumulation of fluid in the abdomen and chest, nausea, vomiting and dehydration may also occur.
This condition occurs when a large number of egg follicles develop. In a moderate case, this can cause some abdominal bloating and discomfort. In a severe case, it can lead to fluid accumulation in the abdomen resulting in a dangerous state of dehydration, and require hospitalization.
OHSS) A potentially serious side effect of follicle stimulating drugs, occurring when too many follicles develop and hCG is given to release the eggs. If ultrasound monitoring shows that too many follicles have matured, OHSS may be prevented by withholding the hCG injection.
Characterized by excessive ovarian enlargement and fluid entering into the abdominal cavity. This usually results in abdominal pain, fluid weight gain and intravascular (inside blood vessels) fluid loss. Blood clotting and/or fluid accumulation into the lung cavity, possible hospitalization and the need for pain medication are all potential occurrences.
A rare side-effect of super-ovulation drug treatment whereby fluid accumulates around major organs.
Ovarian hyperstimulation syndrome (OHSS) is a complication from some forms of fertility medication. Most cases are mild, but a small proportion is severe.